the factors that regulate the development of the nonmalignant constituents of tumors, as well as the influences these constituents exert on the neoplastic compartSummary ment, are poorly understood (Helmlinger et al., 1997; Jain, 1997) . In large measure the scarcity of information We have established a line of transgenic mice expressabout the regulatory circuits that control the interplay ing the A. victoria green fluorescent protein (GFP) unbetween tumor and stroma can be attributed to the der the control of the promoter for vascular endothelial difficulty of simulating the tumor microenvironment in growth factor (VEGF). Mice bearing the transgene show vitro. green cellular fluorescence around the healing marTo begin to study the interactions that lead to tumor gins and throughout the granulation tissue of superfiangiogenesis, we have created and analyzed transgenic cial ulcerative wounds. Implantation of solid tumors mice that express an engineered version of GFP under in the transgenic mice leads to an accumulation of the control of the human VEGF promoter. In these mice green fluorescence resulting from tumor induction of VEGF promoter activation associated with normal wound host VEGF promoter activity. With time, the fluoresrepair is manifested by fluorescence developing at the cent cells invade the tumor and can be seen throughwound margins and extending throughout the granulaout the tumor mass. Spontaneous mammary tumors tion tissue. Following implantation of solid tumors, induced by oncogene expression in the VEGF-GFP intensely fluorescent fibroblasts can be observed surmouse show strong stromal, but not tumor, expression rounding and infiltrating the tumor mass. When spontaof GFP. In both wound and tumor models the predomineous mammary tumors in the VEGF-GFP background nant GFP-positive cells are fibroblasts. The finding that are examined, GFP can be found in fibroblasts surthe VEGF promoter of nontransformed cells is strongly rounding the neoplastic nodules but not in the tumor activated by the tumor microenvironment points to a cells themselves. need to analyze and understand stromal cell collaboration in tumor angiogenesis.
Results Introduction
A reporter for VEGF promoter activity was prepared in The neovascularization of solid tumors facilitates their which an engineered GFP was placed immediately growth and metastasis by providing nutrient flow and a downstream of 2.85 kb of VEGF promoter and 5Ј unfrequently incomplete, fenestrated endothelial barrier translated region. To reduce integration site depenbetween neoplastic cells and circulation (Fidler, 1995;  dence the transcription unit was inserted between tan- Hanahan and Folkman, 1996; Jain, 1997) . The new blood dem copies of the core AT-rich element of the matrix vessels that develop within solid tumors are thought to attachment region located 3Ј to the human beta globin arise as a result of the proliferation and migration of locus. Three pups surviving to maturity were found to endothelial cells from existing vasculature supplying the be transgenic by analysis of DNA prepared from tail tumor bed in a complex process that involves the regusections and were tested for acquisition of green fluolated interaction of several soluble mediators and their rescence around the margins of a lesion generated by cognate receptors (Hanahan, 1997; Risau, 1997) . Ala small full-thickness wound of one ear. All three animals though the mechanisms by which endothelial cells are showed similar responses, but the signal was weak in recruited to the tumor are not completely understood, two. The mouse with the best response was then mated it is well documented that virtually all malignant cells in to generate the transgenic line. Figures 1a and 1b show transmission and fluorescence images obtained by intravital microscopy of a 6 To whom correspondence should be addressed. 7 These authors contributed equally to this work.
healing full-thickness circular incision in the ear of the (a-c) Low power microscopic images of a full-thickness wound in the ear of VEGF-GFP transgenic founder 2 weeks after the wound creation. Transillumination (a) and GFP fluorescence (b and c) images were either photographed (a and b) with ASA 400 film or acquired with the aid of an intensified CCD camera (c). (c) is shown to illustrate the relative intensities of signal observed with the CCD camera and conventional film. All subsequent images (d-i) were recorded digitally and represent GFP expression during wound healing of VEGF-GFP transgenic mice (FVB-C3H F1 hybrid) 1 week (d and g), 2 weeks (e and h), and 3 weeks (f and i) after wound creation. The fluorescence images were digitized and processed at the same instrument settings. One week after the wound creation, weak GFP fluorescence was observed predominantly at the margins of the wound (d and g). Only a few newly formed vessels can be seen localized at the periphery of the wound. Two weeks after wound creation, the GFP fluorescence is brighter and more localized toward the center of the wound (b, c, e, and h). Angiogenesis can be observed in the wound, especially in the peripheral region (a). Three weeks after the wound creation, GFP fluorescence is further increased and advanced toward the center of the wound (f and i). The bar (a) represents 500 m, and the same scale applies to all panels.
founder mouse. Around the incision margins can be Two weeks after wound creation, the GFP fluorescence was brighter and had advanced toward the center of seen distinct green fluorescence arising from local activation of the reporter gene in response to wound-elicited the wound (Figures 1b, 1c , 1e, and 1h). More prominant angiogenesis was observed at this time, especially at the factors. The color images shown in Figure 1 were acquired at day 14 postwounding. In the first few days wound periphery (Figure 1a ). Three weeks after wound creation, GFP fluorescence was further increased and after wound creation a thick scab was observed on the wound. Because the scab showed significant autofluohad continued to advance toward the center of the wound. Observation was discontinued before the ulcers rescence, it was difficult to observe GFP-specific fluorescence while it was present. The scab disappeared that formed at the wound site had completely healed. GFP is a sensitive reporter because it is easily deabout 1 week after wound creation, and the wound was then seen to be partially filled in with granulation tissue.
tected, cell-restricted, and stable. The fluorescence intensity of cells expressing the GFP reporter is a convoluTwo examples of the characteristic time course of GFP expression following full-thickness wounds in founder tion of transcript creation with the decay functions for both mRNA and protein over the natural lifetime of GFP progeny are shown in the lower panels of Figure 1 . Weak GFP fluorescence was observed predominantly at the in vivo. To estimate the relevant parameters, we transfected cells of the U87 (human glioma) and LS174T (humargins of the wound 1 week after wound creation (Figures 1d and 1g) . Only a few newly formed vessels could man colon adenocarcinoma) cell lines with a construct bearing the GFP expression cassette described above be seen, localized at the wound periphery (not shown). hepatocellular carcinoma HCaI, were implanted subcutaneously in dorsal skin chambers attached to transgenic F1 hybrids. Although the distribution and time course of fluorescence are different for the two tumors, fluorescence generally first appears at the margins (Figures 3b, 3c , 3e, and 3h) and penetrates into the tumor mass (Figures 3f, 3i, and 3l ). In the mammary carcinoma, strong fluorescence can often be seen retained about the periphery (e.g., Figure 3c ). Dense vascularization occasionally limits fluorescence detection (Figure 3l ).
Over a longer period of time, the mammary carcinoma organizes and evolves along a somewhat different path than the hepatoma (Figure 4) . Although initially the fluorescent cells are seen exclusively at the tumor periphery, the fluorescent cells appear to penetrate quickly into the HCaI tumors. An example of fluorescence flare during the establishment of such a tumor is shown in the bottom row of Figure 4 . In this sequence a period of intense fluorescence is followed by a diminution of signal intensity as neovasculature appears. It seems likely of the focal plane make it difficult to distinguish cell shapes with precision, intravital confocal microscopy was undertaken. Using this approach, out-of-plane signal under the control of a synthetic tetracycline-responsive was greatly reduced, and similar patterns of cellular fluopromoter (Gossen and Bujard, 1992) . Following growth rescence could be seen around the margins of 3-weekin culture under conditions in which the GFP was fully old wounds or within implanted tumors 3 weeks postiminduced, tetracycline was added to the medium to inactiplantation ( Figure 5 ). Imaging of the tumor and wound vate the promoter, and the total fluorescence activity of at higher magnification showed that individual cells the culture was determined at various times thereafter.
could be detected throughout the tumor mass. In both The recorded values thus provide a measure of fluorescases the fluorescent cells had the extended morpholcence independent of cell proliferation and, hence, indeogy that is characteristic of tissue fibroblasts ( Figure 5 ). pendent of dilution effects attributable to increases in Histologic examination of the implanted breast carcicell size or number. Figure 2 shows that the fluorescence noma and hepatocellular carcinoma at 1 week showed of lysates prepared from the two transfected cell types tumor nodules surrounded by fibroblastic proliferation declined with terminal half-lives of 35.5 hr and 28.3 hr for with no extension into the tumor nodules (Figures 6a U87 and LS174T, respectively. The ordinate intercepts and 6f). The rim of fibroblast proliferation was in the were greater than unity in both cases, consistent with region seen to be extensively populated with green fluoa delay between removal of tetracycline and initiation rescent cells by confocal microscopy. Consistent with of decay that was in strikingly good agreement between this, the fibroblasts from this portion of the section were the two cell lines, 9.6 hr for U87 and 9.8 hr for LS174T.
positive on immunohistochemical staining with a polyAssuming that this lag represents the effective interval clonal anti-GFP antibody (Figure 6e ). At 3 weeks, the for termination of production (i.e., assimilates the time fibroblasts can be seen to extend from the periphery required for both cessation of promoter activity and into the tumor bed, forming fibrous septae (Figures 6b-decay of mRNA), GFP in mammalian cells in culture has 6d). Examination of the skin wound showed fibroblastic an estimated half-life of between 1.2 and 1.5 days. If proliferation underneath the ulcer that fills the wound similar characteristics are applicable to cells in vivo, bed at 3 weeks ( Figure 6g ). No reepithelialization is presthe observed GFP intensity in the photomicrographs ent 1 week after wounding, and the fibroblasts adjacent represents the integral of promoter activity over a natural to and beneath the wound show strong GFP immunore-(exponential) decay interval of approximately 2 days. activity ( Figure 6h ). GFP-positive cells in tumor sections To evaluate VEGF promoter activity in the context of did not stain positive for CD31, a marker of small vessel tumor development, we produced hybrid mice by mating endothelium, nor for CD45 (pan-hematopoietic cell), nor FVB-derived, VEGF-GFP transgenic animals with wild-CD3 (T-lymphoid cell) markers (not shown). On Giemsa type C3H mice. The resulting animals can serve as hosts staining the few cells found to stain metachromatically for well-studied C3H-derived tumor lines. Tumors from were round to oval in shape, consistent with an identification as tissue mast cells. These cells were far less two such lines, the mammary carcinoma MCaIV and the Photomicrographs of MCaIV, a murine mammary carcinoma (a-f) and HCaI, a murine hepatoma (g-l), grown in dorsal skin chambers of VEGF-GFP transgenic mice. The left panels (a, d, g, and j) are transilluminated images at 1 week after tumor implantation, and the middle and right panels are the corresponding fluorescence images at 1 week (b, e, h, and k) and 2 weeks (c, f, i, and l) after the tumor implantation. One week after tumor implantation, marked vessel dilatation was observed in the host vessels surrounding or underneath the tumor xenografts (a and d). GFP fluorescence was initially localized at the tumor-host interface of HCaI tumors (h and k). Two weeks after the tumor implantation, the GFP fluorescence was intensified (c and d) and expanded (i and l). The vasculature in the tumor became apparent at this point. In general, the peripheral region of the tumor (tumor-host interface) shows stronger GFP fluorescence than the center. The bar in (a) represents 500 m, and the same scale is used in all panels.
numerous than the fibroblasts. To make a definitive idenExamination of wound and tumor specimens at 2 weeks (Figures 7d-7h ) also showed proliferation of fibroblasts. tification of the stromal cells, we prepared sections for electron microscopy ( Figure 6i ).
In these specimens the fibroblasts are more mature, containing abundant dilated and undilated rough endoUltrastructural examination of the 1 week tumor specimen (Figure 7a-7c ) revealed proliferation of spindleplasmic reticulum and fewer ribosomes. The extracellular matrix contains more collagen fibers that are being shaped cells adjacent to cohesive nests of tumor cells. The spindle-shaped cells have the features of primitive secreted by the fibroblasts (Figures 7f and 7h) . The spindle-shaped cells did not show intracytoplasmic granules fibroblasts, containing abundant intracytoplasmic ribosomes, rough endoplasmic reticulum, few mitochondria, and bore no prominent intracytoplasmic ribosomes, characteristic of mast cells/histiocytes and lymphoid and pinocytotic vesicles (Figure 7b and 7c) . They are arranged individually and enmeshed within a matrix concells, respectively.
To compare in vivo and in vitro properties, primary taining occasional banded collagen-dilated fibers. were acquired with a digital camera. Data were acquired under identical conditions in all panels. The left panels (a, d, g, and j), the middle panels (b, e, h, and k), and the right panels (c, f, i, and l) represent the same tumor at 1 week, 2 weeks, and 3 weeks after implantation, respectively. GFP fluorescence was generally more intense at the tumor periphery. Note the high degree of correlation between fluorescence and vasculature in (c) and (f). (i) and (l) show only a part of the tumor. The growth rate and angiogenesis varied between individual tumors and tumor types. The bar in (a) represents 1 mm in all panels. embryo fibroblasts were prepared from VEGF-GFP mice of experimental resolution, the VEGF promoter of fibroblasts in culture is induced as strongly as that of fibroand propagated in culture. Flow cytometry of cells grown in culture unexpectedly showed a bimodal patblasts infiltrating implanted tumors. Measurement of the concentration of VEGF in the culture supernatant of fitern of constitutive GFP expression (Figure 8 ). The relative induction of the VEGF promoter under these condibroblasts prepared from transgene-positive and -negative mice showed that the ratio of production by positive tions was determined by comparison of the signal intensities observed in vitro and in vivo. Tumors imcultures compared to negative cultures was 1.24 Ϯ 0.25 (n ϭ 4). Thus, there are no significant differences beplanted in the VEGF-GFP mouse were excised, dissociated, and subjected to flow cytometry. Although the cell tween the endogenous VEGF promoter activity of transgenic and nontransgenic fibroblasts. However, transgenic numbers were small, the fluorescence distribution of the cells recovered from the tumors coincided with the cultures tended to show a decrease in GFP frequency with time, which may reflect a selection against cells fluorescence distribution observed following cytometry of primary cells in culture (Figure 8 ). Thus, to the limit expressing high levels of GFP. Mice bearing the VEGF-GFP transgene were mated lived phenomenon in both the wounds and tumors studwith mice bearing the polyoma middle T antigen under ied here. Strong GFP production associated with prolifthe control of the mouse mammary tumor virus long eration of mesenchymal elements could be seen for terminal repeat promoter. Spontaneous multifocal mamweeks following wounding or tumor implantation. The mary tumors have been shown to appear with high fredistribution and evolution of fluorescence appeared to quency in the latter mice (Guy et al., 1994) . Mice transgenic follow a characteristic course for the two tumor types for both the GFP and the middle T transgenes were studied. The mammary carcinoma developed a more found to develop multiple spontaneous mammary tuseptated fluorescence that remained intense as the mors at ages 4 to 5 months. The mice were sacrificed, tumor grew, whereas the hepatocellular carcinoma deand the lesions were examined for distribution of GFP veloped a diffuse fluorescence that waned as dense by immunohistochemistry. In general the spontaneous vascularity ensued. Both tumor types showed extensive tumors were similar in appearance and organization to penetration of fluorescent cells into the tumor mass. the implanted MCaIV mammary carcinoma, with vascu-A similar picture was seen in the setting of spontanelar plexi apparent in the perineoplastic stroma. No antious tumorigenesis in a transgenic oncogene model. GFP GFP antibody reactivity was detected in the tumor nodimmunoreactivity was apparent around the margins of ules themselves, which were relatively avascular (Figure multifocal tumor nodules. No GFP reactivity was detect-9). In contrast the fibrotic tissue surrounding the nodable in the nodules themselves, suggesting that VEGF ules, which was hyperplastic and vascularized, showed promoter activity in the neoplastic cells was at best numerous scattered cells reactive with anti-GFP antipoorly induced. However, fibroblasts in the fibrotic tubody ( Figure 9 ). Fibroblasts surrounding blood vessels mor matrix were clearly positive for GFP. traversing the stroma stained positive for GFP, whereas
Of the different mechanisms that regulate VEGF proendothelial cells were negative (Figure 9 ). moter strength, hypoxia (Shweiki et al., 1992 ) is best understood. However, in vivo measurements have shown Discussion that the partial oxygen pressure (pO 2) of tumor tissue and vasculature is heterogeneous and vessel perfusion Understanding the factors that govern the growth and rates do not necessarily correlate with local oxygenation metastasis of solid tumors is an important but challeng- (Helmlinger et al., 1997) . Although malignant neoplasms ing objective. Much of the difficulty in understanding can develop impressive vascularity, the vasculature is tumor dynamics comes from the complexity of the eximperfect, disordered and leaky, and poorly conducts perimental systems in vivo and from the failure of in nutrients and erythrocytes through the tumor mass vitro culture models to faithfully reflect events taking (Jain, 1997) . As a result the tumor shows irregular, conplace in an organismic context. In the studies reported stantly changing patterns of metabolic demand that may here, intravital microscopy and a sensitive intracellular be expected to induce cognate fluctuations in VEGF reporter have been exploited to increase our undertranscriptional activity. standing of the interplay between neoplastic cells and VEGF mRNA accumulation in vivo is also regulated the underlying stromal bed. Using a transgenic animal by prolongation of mRNA half-life through posttranline in which the VEGF promoter drives the expression scriptional regulatory events mediated by specific cisof GFP, we have been able to detect and track activation sequences encoded in the mRNA 3Ј untranslated region of the VEGF promoter in response to wounding and (Shima et al., 1995; Stein et al., 1995; Levy et al., 1996; neoplasia. VEGF transcriptional activation was a surprisingly longDamert et al., 1997). Because the reporter construct described in this work does not contain the 3Ј untransculture conditions that mimic the status of normal (unactivated) tissue in vivo. lated region, it does not assimilate mRNA stability effects.
In normal rat primary fibroblasts grown in culture, hypoxia induces a G 0 /G 1 checkpoint that results in growth In both normal wound recovery and neoplasia, the most prominent cells showing VEGF promoter activation arrest, whereas the same conditions cause transformed fibroblasts to undergo apoptosis (Graeber et al., 1994 ; are spindle-shaped cells that ultrastructurally display classic features of fibroblasts and do not show external Schmaltz et al., 1998) . Because our findings point to a potentially important role for fibroblasts in VEGF produclamina, junctions, tonofilaments, lumen formation, Weibel-Palade bodies, or other structural features suggestion, the report that hypoxia induces growth arrest in vitro is unexpected and further suggests the importance tive of keratinocyte or endothelial cells. The cells are not sessile, but migrate into the wound or tumor, preof studying events in vivo. Similarly, the finding that fibroblasts in culture show highly induced VEGF transumably under the influence of as-yet-unidentified chemotactic factors. Fibroblasts recovered from the tumor scriptional activity clearly indicates that other factors than hypoxia can significantly affect promoter strength. mass and analyzed by flow cytometry have the same fluorescence profiles as fibroblasts propagated in cul-VEGF is widely expressed in normal tissues (Berse et al., 1992) , and its promoter region bears many of the ture. We conclude from this that fibroblasts grown under standard conditions in vitro are as activated with respect characteristics of housekeeping genes (Tischer et al., 1991) . Hence, it seems likely that in principle almost any to VEGF promoter activity as fibroblasts in tumors. This rather surprising observation suggests that culture in cell type could serve as a source for VEGF upon hypoxic or ischemic demand. In the context of wound angiogenvitro is highly activating for VEGF promoter function and that additional effort will need to be expended to find esis, previous studies have focused on the role of kera- tinocytes. In culture these cells respond to growth factissue can be attributed to fibroblasts. Although it is likely that more superficial wounds would show a tors and cytokines with increased VEGF production (Frank et al., 1995) , and shorter term studies of epidermal greater keratinocyte involvement, it is significant that the wounds in this study did not heal well and that wounds using in situ hybridization have identified them as a major source of VEGF transcripts (Brown et al., striking similarities were observed between the pattern of induction of VEGF promoter activity in the wounds 1992). The wounds created in this study were ulcerative full-thickness excisions that generally showed little reand implanted tumors, consistent with the earlier suggestion that tumors behave as wounds that do not heal epithelialization and healed poorly. Imaging of GFP fluorescence during the period in which the keratinocyte (Dvorak, 1986) . At present the relative contributions of tumor and contribution was previously reported to be dominant (Brown et al., 1992) proved difficult because of the high stroma to endothelial cell proliferation and migration are not understood. Although data from in vitro measurelevel of autofluorescence associated with scab formation. During the later granulation phase, few of the fluoments of VEGF production by tumor cells in culture have led to the assumption that the tumor is the principal if rescent cells appeared to be epithelial in origin, and the principal contribution to fluorescence in the granulation not sole source of VEGF, the results of this work point to the possibility that stromal elements play an important allows transformed cells to rapidly acquire resistance to chemotherapeutic agents (Kerbel, 1991; Kim et al., role Fidler, 1995; Parangi et al., 1996 ; Boehm et al., breast tissue have been shown to produce VEGF in 1997). A better understanding of stromal contributions culture (Hlatky et al., 1994) , and our findings indicate will likely increase our awareness of the importance of that fibroblasts from other sources likely behave simiother molecules than VEGF in the growth of solid maliglarly. The finding that stromal fibroblasts penetrate deep nancies and may result in the identification of new therainto implanted tumors raises the need to consider peutic targets for future treatments focusing on the tuwhether fibroblasts serve other functions besides promor stroma. duction of VEGF, possibly including the production of chemotactic factors that elicit endothelial cell migration.
Experimental Procedures
In addition, it is presently unclear what fraction of neovascular growth can be attributed to VEGF as opposed
Constructs and Reagents
to other polypeptides that have endothelial cell mitoEight hundred base pairs of the core matrix attachment region from genic potential, such as basic fibroblast growth factor. the human beta globin 3Ј DNaseI hypersensitive site (Fleenor and Kaufman, 1993) , comprising nucleotides 1601 to 2400 of GenBank Targeting antitumor therapy to stromal elements re-X54282, were placed between MluI and SpeI sites upstream and quired for tumor growth may be a superior strategy for between BamHI and NheI sites downstream of a GFP expression retarding the growth of solid neoplasms, since normal vector consisting of a codon-optimized GFP bearing two mutations tissue is unlikely to show the genetic plasticity that often (FS64LT) upstream of a human IgG1 intron and an SV40 polyadenylation sequence (Cormack et al., 1996; Haas et al., 1996; Heim and accompanies malignant transformation, a plasticity that , 1996) . VEGF promoter sequences from 552 to 3401 of GenSections were stained by avidin biotin complex methods as described previously (Cerf-Bensussan et al., 1983; Hollander et al., Bank M63971 (Tischer et al., 1991) were inserted between SpeI and HindIII to give the expression cassette. 1995). Tissue sections (4 m) were air-dried for 10 min, fixed in acetone, and air-dried again for 10 min. Sections were then incubated in primary rabbit polyclonal antibodies to GFP (Clontech Wound Preparation 1:100) for 1 hr. Secondary antibodies that were biotin-and cy3/5-Wounds were created using a modified technique previously delabeled were used to detect primary antibody staining for immunoscribed (Bondá r et al., 1991) . Mice were anesthetized with Ketamine histochemistry and confocal microscopy, respectively. Each step 90 mg/kg (Parke-Davis, Morris Plains, NJ) and Xylazine 9 mg/kg was followed by three washes in phosphate-buffered saline. The (Fermenta, Kansas City, MO). Prior to excision, the overlying hair of sections were then incubated with ABC reagent, followed by postfixthe mouse ear was removed with a depilatory cream (Neet, Reckitt ation in 2% paraformaldehyde, and counter stained with hemaand Colman Inc., Wayne, NJ). The dorsal skin layer of the ear, down toxylin. to but not including the cartilage, was excised with microscissors under a disecting microscope to provide a full-thickness wound of approximately 2 mm in diameter. One, two, and three weeks after Electron Microscopy wound creation, mice were anesthetized, the ears with the healing Tissues from four mice were processed for electron microscopy. wound were gently placed on the transparent observation platform, They were fixed in Karnovsky II solution and stored in sodium cacoand a thin circular cover glass (11 mm in diameter) with one drop dylate buffer. They were then postfixed in osmium tetroxide, stained of saline was placed on top (Detmar et al., 1998; Milstone et al., en bloc with uranyl acetate, dehydrated in graded ethanol solutions, 1998).
infiltrated with propylene oxide/epoxy resin, and embedded in epoxy resin. One micrometer sections were cut, stained with toluidine blue, Dorsal Skin Chamber/Tumor Preparation and examined by light microscopy. Representative sections were Dorsal skin chambers were implanted in mice using a procedure chosen for thin sectioning. Thin sections were cut, stained with lead described elsewhere (Leunig et al., 1992) . A small piece (1 mm citrate, and examined in a Philips 301 electron microscope. diameter) of MCaIV (a murine mammary adenocarcinoma) or HCaI (a murine hepatocellular carcinoma) tumor tissue was implanted at Acknowledgments the center of the dorsal chamber. Observations were made 1, 2, and 3 weeks after tumor implantation. The animals were positioned
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